# Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease

> **NCT06021756** · PHASE1 · UNKNOWN · sponsor: **University of Arizona** · enrollment: 9 (actual)

## Conditions studied

- Levodopa-Induced Dyskinesia
- Parkinson's Disease

## Interventions

- **DRUG:** Intervention: Ketamine

## Key facts

- **NCT ID:** NCT06021756
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-28
- **Primary completion:** 2022-08-25
- **Final completion:** 2023-08-25
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-09-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06021756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06021756, "Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06021756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*